ArticleScientific reports2026
A comprehensive evaluation on the bioactivity, antibacterial efficacy and cell viability of PVA-PVP-chitosan electrospun scaffolds reinforced with calcium/zinc silicate.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Freeze-Dried CS/PVP/PVA Composite Scaffolds Doped with Curcumin and SiOInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various silicate compounds have been extensively used for scaffold fabrication via electrospinning. However, harnessing the bioactive properties of Calcium silicate (CS) and Zinc silicate (ZS) are less explored in electrospinning. This work discusses the fabrication of PVA-PVP-Chitosan polymer-matrix scaffolds via electrospinning incorporating various percentages of Calcium Silicate/Zinc silicate and the scaffolds are named as PPCC1, PPCC2, and PPCC3 for CS incorporated scaffolds and PPCZ1, PPCZ2 and PPCZ3 for ZS incorporated scaffolds. The biomineralization assay prove bioactivity of the scaffolds and apatite formation was observed within 3 days of immersion. Analysis of the fiber diameter show the direct influence of the presence of ceramics in the scaffolds. When the concentration of CS changed from 0. 5% to 2%, the fiber diameter reduces from 249 to 70 nm. At higher ceramics content, PPCC3 has a tensile strength of 2.79 MPa whereas the tensile strength of PPCZ3 is 2.2 MPa due to the presence of nodules in the scaffold that reduce mechanical stability. All the scaffolds are hydrophilic, their contact angle ranging from 71 − 46°. Due to faster dissociation of Ca ions, CS incorporated scaffold show a faster biodegradation rate than ZS incorporated scaffolds. Since both types scaffolds exhibit < 70% cell viability, they can be effectively used for bone regeneration applications without any adverse effects. ALP activity for CS incorporated scaffold is observed to be 143.07 ± 4.41 U/L on 3rd day and 253.27 ± 5.69 U/L on 7th day. The activity of ZS incorporated scaffold is shown to be 216.03 ± 4.34 U/L on 3rd day and 362.41 ± 3.87 U/L on 7th day.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.